Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4041)
All Articles published online
|
Mar 14, 2006 (publication date) through Dec 2, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Engwegen JY, Helgason HH, Cats A, Harris N, Bonfrer JM, Schellens JH, Beijnen JH. Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry. World J Gastroenterol 2006; 12(10): 1536-1544 [PMID: 16570345 DOI: 10.3748/wjg.v12.i10.1536] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i10/1536.htm |
| Number | Citing Articles |
| 1 |
C. M. Annunziata, N. Azad, A. S. Dhamoon, G. Whiteley, E. C. Kohn. Ovarian cancer in the proteomics era. International Journal of Gynecologic Cancer 2008; 18(Suppl 1): 1 doi: 10.1111/j.1525-1438.2007.01096.x
|
| 2 |
Wataru Kikuchi, Motoi Nishimura, Takahisa Kuga, Sachio Tsuchida, Tatsuya Saito, Mamoru Satoh, Kenta Noda, Yoshio Kodera, Takeshi Tomonaga, Fumio Nomura. Fibrinogen alpha C chain 5.9 kDa fragment (FIC5.9), a biomarker for various pathological conditions, is produced in post-blood collection by fibrinolysis and coagulation factors. Clinical Proteomics 2016; 13(1) doi: 10.1186/s12014-016-9129-6
|
| 3 |
Current literature in mass spectrometry. Journal of Mass Spectrometry 2007; 42(4): 547 doi: 10.1002/jms.1073
|
| 4 |
Marie-Christine W Gast, Judith YMN Engwegen, Jan HM Schellens, Jos H Beijnen. Comparing the old and new generation SELDI-TOF MS: implications for serum protein profiling. BMC Medical Genomics 2008; 1(1) doi: 10.1186/1755-8794-1-4
|
| 5 |
Kewal K. Jain. Innovations, challenges and future prospects of oncoproteomics. Molecular Oncology 2008; 2(2): 153 doi: 10.1016/j.molonc.2008.05.003
|
| 6 |
Masaki Shibayama, Matthias Maak, Ulrich Nitsche, Kengo Gotoh, Robert Rosenberg, Klaus-Peter Janssen. Prediction of Metastasis and Recurrence in Colorectal Cancer Based on Gene Expression Analysis: Ready for the Clinic?. Cancers 2011; 3(3): 2858 doi: 10.3390/cancers3032858
|
| 7 |
J. Holcakova, L. Hernychova, P. Bouchal, K. Brozkova, J. Zaloudik, D. Valik, R. Nenutil, B. Vojtesek. Identification of αB-Crystallin, a Biomarker of Renal Cell Carcinoma by SELDI-TOF MS. The International Journal of Biological Markers 2008; 23(1): 48 doi: 10.1177/172460080802300108
|
| 8 |
L. C. Whelan, K. A. R. Power, D. T. McDowell, J. Kennedy, W. M. Gallagher. Applications of SELDI‐MS technology in oncology. Journal of Cellular and Molecular Medicine 2008; 12(5a): 1535 doi: 10.1111/j.1582-4934.2008.00250.x
|
| 9 |
Peter Findeisen, Michael Neumaier. Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective. Clinical Chemistry and Laboratory Medicine 2009; 47(6) doi: 10.1515/CCLM.2009.159
|
| 10 |
Alejandro García-Muñoz, Mario A Rodríguez, Ronell Bologna-Molina, Febe E Cázares-Raga, Fidel C Hernández-Hernández, J Eduardo Farfán-Morales, Juan J Trujillo, Carlos Licéaga-Escalera, Guillermo Mendoza-Hernández. The orosomucoid 1 protein (α1 acid glycoprotein) is overexpressed in odontogenic myxoma. Proteome Science 2012; 10(1) doi: 10.1186/1477-5956-10-49
|
| 11 |
Feng Jiang, Xiang-Yu Zhou, Jing Huang. The Value of Surface Enhanced Laser Desorption/Ionization-Time of Flight Mass Spectrometry at the Diagnosis of Non-Small Cell Lung Cancer: A Systematic Review. Technology in Cancer Research & Treatment 2014; 13(2): 109 doi: 10.7785/tcrt.2012.500360
|
| 12 |
Marie-Christine W. Gast, Eric J. van Dulken, Thea K.G. van Loenen, Florine Kingma-Vegter, Johan Westerga, Claudie C. Flohil, Jaco C. Knol, Connie R. Jimenez, Carla H. van Gils, Lodewijk F.A. Wessels, Jan H.M. Schellens, Jos H. Beijnen. Detection of Breast Cancer by Surface-enhanced Laser Desorption/Ionization Time-of-flight Mass Spectrometry Tissue and Serum Protein Profiling. The International Journal of Biological Markers 2009; 24(3): 130 doi: 10.1177/172460080902400302
|
| 13 |
Junjie Zhang, Fei Guo, Lei Wang, Wei Zhao, Da Zhang, Heying Yang, Jiekai Yu, Lili Niu, Fuquan Yang, Shu Zheng, Jiaxiang Wang. Identification of Apolipoprotein C-I as a Potential Wilms’ Tumor Marker after Excluding Inflammatory Factors. International Journal of Molecular Sciences 2014; 15(9): 16186 doi: 10.3390/ijms150916186
|
| 14 |
Hao Jiang, Jing-Yuan Tang, Dong Xue, Yi-Meng Chen, Ting-Chun Wu, Qian-Feng Zhuang, Xiao-Zhou He. Apolipoprotein C1 stimulates the malignant process of renal cell carcinoma via the Wnt3a signaling. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-020-01713-x
|
| 15 |
A. A. Terentiev, N. T. Moldogazieva, K. V. Shaitan. Dynamic proteomics in modeling of the living cell. Protein-protein interactions. Biochemistry (Moscow) 2009; 74(13): 1586 doi: 10.1134/S0006297909130112
|
| 16 |
Candidate biomarker verification: Critical examination of a serum protein pattern for human colorectal cancer. PROTEOMICS – Clinical Applications 2012; 6(3-4): 182 doi: 10.1002/prca.201100095
|
| 17 |
Douglas G Ward, Stephen Nyangoma, Howard Joy, Emma Hamilton, Wenbin Wei, Chris Tselepis, Neil Steven, Michael JO Wakelam, Philip J Johnson, Tariq Ismail, Ashley Martin. Proteomic profiling of urine for the detection of colon cancer. Proteome Science 2008; 6(1) doi: 10.1186/1477-5956-6-19
|
| 18 |
Mary E. Ziegler, Tingchao Chen, James F. LeBlanc, Xuelian Wei, David W. Gjertson, Ker-Chau Li, Mazdak A. Khalighi, Charles R. Lassman, Jeffrey L. Veale, H. Albin Gritsch, Elaine F. Reed. Apolipoprotein A1 and C-Terminal Fragment of α-1 Antichymotrypsin Are Candidate Plasma Biomarkers Associated With Acute Renal Allograft Rejection. Transplantation 2011; 92(4): 388 doi: 10.1097/TP.0b013e318225db6a
|
| 19 |
Judith Y.M.N. Engwegen, Marie-Christine W. Gast, Jan H.M. Schellens, Jos H. Beijnen. Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometry. Trends in Pharmacological Sciences 2006; 27(5): 251 doi: 10.1016/j.tips.2006.03.003
|
| 20 |
Yinghua Qiu, Tasneem H. Patwa, Li Xu, Kerby Shedden, David E. Misek, Missy Tuck, Gracie Jin, Mack T. Ruffin, Danielle K. Turgeon, Sapna Synal, Robert Bresalier, Norman Marcon, Dean E. Brenner, David M. Lubman. Plasma Glycoprotein Profiling for Colorectal Cancer Biomarker Identification by Lectin Glycoarray and Lectin Blot. Journal of Proteome Research 2008; 7(4): 1693 doi: 10.1021/pr700706s
|
| 21 |
Marie-Christine W. Gast, Carla H. van Gils, Lodewijk F.A. Wessels, Nathan Harris, Johannes M.G. Bonfrer, Emiel J.Th. Rutgers, Jan H.M. Schellens, Jos H. Beijnen. Influence of sample storage duration on serum protein profiles assessed by surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry (SELDI-TOF MS). Clinical Chemistry and Laboratory Medicine 2009; 47(6) doi: 10.1515/CCLM.2009.151
|
| 22 |
Thomas Göbel, Sonja Vorderwülbecke, Katarzyna Hauck, Holger Fey, Dieter Häussinger, Andreas Erhardt. New multi protein patterns differentiate liver fibrosis stages and hepatocellular carcinoma in chronic hepatitis C serum samples. World Journal of Gastroenterology 2006; 12(47): 7604-7612 doi: 10.3748/wjg.v12.i47.7604
|
| 23 |
ME de Noo, RAEM Tollenaar, AM Deelder, LH Bouwman. Current status and prospects of clinical proteomics studies on detection of colorectal cancer: Hopes and fears. World Journal of Gastroenterology 2006; 12(41): 6594-6601 doi: 10.3748/wjg.v12.i41.6594
|
| 24 |
John F Timms, Elif Arslan-Low, Aleksandra Gentry-Maharaj, Zhiyuan Luo, Davy T’Jampens, Vladimir N Podust, Jeremy Ford, Eric T Fung, Alex Gammerman, Ian Jacobs, Usha Menon. Preanalytic Influence of Sample Handling on SELDI-TOF Serum Protein Profiles. Clinical Chemistry 2007; 53(4): 645 doi: 10.1373/clinchem.2006.080101
|
| 25 |
Chafika Mazouni, Keith Baggerly, David Hawke, Spyros Tsavachidis, Fabrice André, Aman U. Buzdar, Pierre‐Marie Martin, Ryuji Kobayashi, Lajos Pusztai. Evaluation of changes in serum protein profiles during neoadjuvant chemotherapy in HER2‐positive breast cancer using an LC‐MALDI‐TOF/MS procedure. PROTEOMICS 2010; 10(19): 3525 doi: 10.1002/pmic.201000057
|
| 26 |
Ming Lu, Kym F. Faull, Julian P. Whitelegge, Jianbo He, Dejun Shen, Romaine E. Saxton, Helena R. Chang. Proteomics and Mass Spectrometry for Cancer Biomarker Discovery. Biomarker Insights 2007; 2: 117727190700200 doi: 10.1177/117727190700200005
|
| 27 |
Yun Liu, Fangqiao Wei, Feng Wang, Changdong Li, Ge Meng, Hua Duan, Qingwei Ma, Weiyuan Zhang. Serum peptidome profiling analysis for the identification of potential biomarkers in cervical intraepithelial neoplasia patients. Biochemical and Biophysical Research Communications 2015; 465(3): 476 doi: 10.1016/j.bbrc.2015.08.042
|
| 28 |
Santiago Marfà, Wladimiro Jimenez. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2017; : 493 doi: 10.1007/978-94-007-7675-3_7
|
| 29 |
Gaayathri Kumarasamy, Nurul Hakimah Mohd Salim, Nur Syafiqah Mohd Afandi, Mohd Afiq Hazlami Habib, Nor Datiakma Mat Amin, Mohd Nazri Ismail, Marahaini Musa. Glycoproteomics-Based Liquid Biopsy: Translational Outlook for Colorectal Cancer Clinical Management in Southeast Asia. Future Oncology 2023; 19(34): 2313 doi: 10.2217/fon-2023-0704
|
| 30 |
Ashraf G. Madian, Nishi S. Rochelle, Fred E. Regnier. Mass-Linked Immuno-Selective Assays in Targeted Proteomics. Analytical Chemistry 2013; 85(2): 737 doi: 10.1021/ac302071k
|
| 31 |
Hao Wang, Chenghua Luo, Shengtao Zhu, Honghong Fang, Qing Gao, Siqi Ge, Haixia Qu, Qingwei Ma, Hongwei Ren, Youxin Wang, Wei Wang. Serum peptidome profiling for the diagnosis of colorectal cancer: discovery and validation in two independent cohorts. Oncotarget 2017; 8(35): 59376 doi: 10.18632/oncotarget.19587
|
| 32 |
Hangyu Zhang, Yongfang Wang, Changgang Liu, Wentong Li, Fenghua Zhou, Xinbo Wang, Jie Zheng. The Apolipoprotein C1 is involved in breast cancer progression via EMT and MAPK/JNK pathway. Pathology - Research and Practice 2022; 229: 153746 doi: 10.1016/j.prp.2021.153746
|
| 33 |
HELGI H. HELGASON, JUDITH Y.M.N. ENGWEGEN, MARK ZAPATKA, ANNEMIEKE CATS, HENK BOOT, JOS H. BEIJNEN, JAN H.M. SCHELLENS. Serum proteomics and disease-specific biomarkers of patients with advanced gastric cancer. Oncology Letters 2010; 1(2): 327 doi: 10.3892/ol_00000058
|
| 34 |
Nai-Jun Fan, Rui Kang, Xue-Yan Ge, Ming Li, Yan Liu, Hong-Mei Chen, Chun-Fang Gao. Identification alpha-2-HS-glycoprotein precursor and tubulin beta chain as serology diagnosis biomarker of colorectal cancer. Diagnostic Pathology 2014; 9(1) doi: 10.1186/1746-1596-9-53
|
| 35 |
Annemieke W.J. Opstal‐van Winden, Jos H. Beijnen, Arnoud Loof, Waander L. van Heerde, Roel Vermeulen, Petra H.M. Peeters, Carla H. van Gils. Search for Breast Cancer Biomarkers in Fractionated Serum Samples by Protein Profiling With SELDI‐TOF MS. Journal of Clinical Laboratory Analysis 2012; 26(1): 1 doi: 10.1002/jcla.20492
|
| 36 |
Kenta Noda, Kazuyuki Sogawa, Wataru Kikuchi, Iwao Kiyokawa, Toshihide Miura, Ryo Kojima, Katsuhiro Katayama, Yoshio Kodera, Fumio Nomura. Development of a sandwich ELISA for the 5.9‐kDa fibrinogen alpha C chain fragment detected by serum proteome analysis. PROTEOMICS – Clinical Applications 2011; 5(3-4): 141 doi: 10.1002/prca.201000127
|
| 37 |
Zhihua Li, Junnan Chen, Bin Xu, Wei Zhao, Haoran Zha, Yalin Han, Wennan Shen, Yuemei Dong, Nan Zhao, Manze Zhang, Kun He, Zhaoxia Li, Xiaoqing Liu. Correlation between small-cell lung cancer serum protein/peptides determined by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and chemotherapy efficacy. Clinical Proteomics 2024; 21(1) doi: 10.1186/s12014-024-09483-8
|
| 38 |
Nicola Marchi, Peter Mazzone, Vincent Fazio, Tarek Mekhail, Thomas Masaryk, Damir Janigro. ProApolipoprotein A1. Cancer 2008; 112(6): 1313 doi: 10.1002/cncr.23314
|
| 39 |
CHIBO LIU, CHUNQIN PAN, YONG LIANG. Screening and identification of serum proteomic biomarkers for gastric adenocarcinoma. Experimental and Therapeutic Medicine 2012; 3(6): 1005 doi: 10.3892/etm.2012.515
|
| 40 |
Ye‐Sheng Wei, Yan‐Hua Zheng, Wei‐Bo Liang, Jian‐Zhong Zhang, Zhi‐Hui Yang, Mei‐Li Lv, Jing Jia, Lin Zhang. Identification of serum biomarkers for nasopharyngeal carcinoma by proteomic analysis. Cancer 2008; 112(3): 544 doi: 10.1002/cncr.23204
|
| 41 |
Q.‐Y. Hu, J. Su, H. Jiang, L.‐L. Wang, Y.‐Q. Jia. Potential role of proteomics in the diagnosis of lymphoma: a meta‐analysis. International Journal of Laboratory Hematology 2013; 35(4): 367 doi: 10.1111/ijlh.12032
|
| 42 |
Magnus Palmblad, Ali Tiss, Rainer Cramer. Mass spectrometry in clinical proteomics – from the present to the future. PROTEOMICS – Clinical Applications 2009; 3(1): 6 doi: 10.1002/prca.200800090
|
| 43 |
Annemieke W. J. Opstal-van Winden, Roel C. H. Vermeulen, Petra H. M. Peeters, Jos H. Beijnen, Carla H. van Gils. Early diagnostic protein biomarkers for breast cancer: how far have we come?. Breast Cancer Research and Treatment 2012; 134(1): 1 doi: 10.1007/s10549-011-1907-2
|
| 44 |
Andrew Rundle, Habibul Ahsan, Paolo Vineis. Better cancer biomarker discovery through better study design. European Journal of Clinical Investigation 2012; 42(12): 1350 doi: 10.1111/j.1365-2362.2012.02727.x
|
| 45 |
Anna Bodzon-Kulakowska, Anna Bierczynska-Krzysik, Tomasz Dylag, Anna Drabik, Piotr Suder, Marek Noga, Justyna Jarzebinska, Jerzy Silberring. Methods for samples preparation in proteomic research. Journal of Chromatography B 2007; 849(1-2): 1 doi: 10.1016/j.jchromb.2006.10.040
|
| 46 |
Hu Qiong-ying, Kai-zheng Wang, Yin-huan Ding, Lv-fang Zheng, Shuang-hua Liang, Zheng-ming Lei, Wen-guang Fu, Li Yan. Application of SELDI-TOF-MS Coupled With an Artificial Neural Network Model to the Diagnosis of Pancreatic Cancer. Laboratory Medicine 2010; 41(11): 676 doi: 10.1309/LMH6TUOMQKX6V2DN
|
| 47 |
Jose L. Luque-Garcia, Thomas A. Neubert. Sample preparation for serum/plasma profiling and biomarker identification by mass spectrometry. Journal of Chromatography A 2007; 1153(1-2): 259 doi: 10.1016/j.chroma.2006.11.054
|
| 48 |
Gary L. Nelsestuen, Stephen B. Harvey, Yan Zhang, Raj S. Kasthuri, Alan R. Sinaiko, E. Wesley Ely, Gordon R. Bernard, Monika Homoncik, Bernd Jilma. Top‐down proteomic analysis by MALDI‐TOF profiling: Concentration‐independent biomarkers. PROTEOMICS – Clinical Applications 2008; 2(2): 158 doi: 10.1002/prca.200780107
|
| 49 |
Ilaria Chiodi, A. Ivana Scovassi, Chiara Mondello. Translational Toxicology and Therapeutics: Windows of Developmental Susceptibility in Reproduction and Cancer. 2017; : 607 doi: 10.1002/9781119023647.ch16
|
| 50 |
Wei‐peng Su, Li‐na Sun, Shun‐liang Yang, Hu Zhao, Teng‐yue Zeng, Wei‐zhen Wu, Dong Wang. Apolipoprotein C1 promotes prostate cancer cell proliferation in vitro. Journal of Biochemical and Molecular Toxicology 2018; 32(7) doi: 10.1002/jbt.22158
|
| 51 |
P Kelly, V Appleyard, K Murray, F Paulin, D Lamont, L Baker, S Suttie, D Exon, A Thompson. Detection of oesophageal cancer biomarkers by plasma proteomic profiling of human cell line xenografts in response to chemotherapy. British Journal of Cancer 2010; 103(2): 232 doi: 10.1038/sj.bjc.6605741
|
| 52 |
Lay Cheng Lim, Mee Lee Looi, Syed Zulkifli Syed Zakaria, Ismail Sagap, Isa Mohammed Rose, Siok-Fong Chin, Rahman Jamal. Identification of Differentially Expressed Proteins in the Serum of Colorectal Cancer Patients Using 2D-DIGE Proteomics Analysis. Pathology & Oncology Research 2016; 22(1): 169 doi: 10.1007/s12253-015-9991-y
|
| 53 |
Jung‐Won Choi, Hao Liu, Dong Hoon Shin, Gyeong Im Yu, Jae Seok Hwang, Eun Soo Kim, Jong Won Yun. Proteomic and cytokine plasma biomarkers for predicting progression from colorectal adenoma to carcinoma in human patients. PROTEOMICS 2013; 13(15): 2361 doi: 10.1002/pmic.201200550
|
| 54 |
Sanket P. Borgaonkar, Harrison Hocker, Hyunjin Shin, Mia K. Markey. Comparison of Normalization Methods for the Identification of Biomarkers Using MALDI-TOF and SELDI-TOF Mass Spectra. OMICS: A Journal of Integrative Biology 2010; 14(1): 115 doi: 10.1089/omi.2009.0082
|
| 55 |
Petra Hudler, Nina Kocevar, Radovan Komel. Proteomic Approaches in Biomarker Discovery: New Perspectives in Cancer Diagnostics. The Scientific World Journal 2014; 2014: 1 doi: 10.1155/2014/260348
|
| 56 |
Michael C.J. Quinn, Abdelali Filali‐Mouhim, Diane M. Provencher, Anne‐Marie Mes‐Masson, Patricia N. Tonin. Reprogramming of the transcriptome in a novel chromosome 3 transfer tumor suppressor ovarian cancer cell line model affected molecular networks that are characteristic of ovarian cancer. Molecular Carcinogenesis 2009; 48(7): 648 doi: 10.1002/mc.20511
|
| 57 |
José Manuel González-Buitrago, Laura Ferreira, María Del Carmen Muñiz. Proteómica clínica y nuevos biomarcadores en los líquidos biológicos. Medicina Clínica 2008; 131(11): 426 doi: 10.1157/13126219
|
| 58 |
Seamus M McHugh, Jill O'Donnell, Peter Gillen. Genomic and oncoproteomic advances in detection and treatment of colorectal cancer. World Journal of Surgical Oncology 2009; 7(1) doi: 10.1186/1477-7819-7-36
|
| 59 |
Mamoun Ahram, Emanuel F. Petricoin. Proteomics Discovery of Disease Biomarkers. Biomarker Insights 2008; 3: BMI.S689 doi: 10.4137/BMI.S689
|
| 60 |
David F. Ransohoff, Christopher Martin, Wesley S. Wiggins, Ben A. Hitt, Temitope O. Keku, Joseph A. Galanko, Robert S. Sandler. Assessment of Serum Proteomics to Detect Large Colon Adenomas. Cancer Epidemiology, Biomarkers & Prevention 2008; 17(8): 2188 doi: 10.1158/1055-9965.EPI-07-2767
|
| 61 |
Biomarker Signature Discovery from Mass Spectrometry Data. IEEE/ACM Transactions on Computational Biology and Bioinformatics 2014; 11(4): 766 doi: 10.1109/TCBB.2014.2318718
|
| 62 |
Päivi Sirniö, Juha P. Väyrynen, Kai Klintrup, Jyrki Mäkelä, Markus J. Mäkinen, Tuomo J. Karttunen, Anne Tuomisto. Decreased serum apolipoprotein A1 levels are associated with poor survival and systemic inflammatory response in colorectal cancer. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-05415-9
|
| 63 |
Sergio Ciordia, Vivian de los Ríos, Juan-Pablo Albar. Contributions of advanced proteomics technologies to cancer diagnosis. Clinical and Translational Oncology 2006; 8(8): 566 doi: 10.1007/s12094-006-0062-4
|
| 64 |
Kwasi Antwi, Galen Hostetter, Michael J. Demeure, Benjamin A. Katchman, G. Anton Decker, Yvette Ruiz, Timothy D. Sielaff, Lawrence J. Koep, Douglas F. Lake. Analysis of the Plasma Peptidome from Pancreas Cancer Patients Connects a Peptide in Plasma to Overexpression of the Parent Protein in Tumors. Journal of Proteome Research 2009; 8(10): 4722 doi: 10.1021/pr900414f
|
| 65 |
Desta Kassa, Leonie Ran, Wilco de Jager, Theo van den Broek, Ronald Jacobi, Muluberhan Mekonen, Tsehaynesh Messele, Mariëlle C. Haks, Tom H.M. Ottenhoff, Debbie van Baarle. Discriminative expression of whole blood genes in HIV patients with latent and active TB in Ethiopia. Tuberculosis 2016; 100: 25 doi: 10.1016/j.tube.2016.06.003
|
| 66 |
Kaori Yamamoto-Ishikawa, Hiroyoshi Suzuki, Masahiko Nezu, Naoto Kamiya, Takashi Imamoto, Akira Komiya, Kazuyuki Sogawa, Takeshi Tomonaga, Fumio Nomura, Tomohiko Ichikawa. The isolation and identification of apolipoprotein C-I in hormone-refractory prostate cancer using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. Asian Journal of Andrology 2009; 11(3): 299 doi: 10.1038/aja.2008.38
|
| 67 |
Matilda Holm, Sakari Joenväärä, Mayank Saraswat, Tiialotta Tohmola, Ari Ristimäki, Risto Renkonen, Caj Haglund. Differences and overlap in plasma protein expression during colorectal cancer progression. Translational Medicine Communications 2019; 4(1) doi: 10.1186/s41231-019-0044-5
|
| 68 |
Judith Y M N Derijks-Engwegen, Annemieke Cats, Marianne E Smits, Jan H M Schellens, Jos H Beijnen. Improving Colorectal Cancer Management: The Potential of Proteomics. Biomarkers in Medicine 2008; 2(3): 253 doi: 10.2217/17520363.2.3.253
|
| 69 |
Annemieke WJ Opstal-van Winden, Esmeralda JM Krop, Monica H Kåredal, Marie-Christine W Gast, Christian H Lindh, Marina C Jeppsson, Bo AG Jönsson, Diederick E Grobbee, Petra HM Peeters, Jos H Beijnen, Carla H van Gils, Roel CH Vermeulen. Searching for early breast cancer biomarkers by serum protein profiling of pre-diagnostic serum; a nested case-control study. BMC Cancer 2011; 11(1) doi: 10.1186/1471-2407-11-381
|
| 70 |
Yanying Wang, Gaoguang Song, Yanmin Wang, Ling Qiu, Xuzhen Qin, Hui Liu, Fang Li, Xiaodong Wang, Fenjie Li, Shuai Guo, Yaping Zhang, Zhili Li. Elevated Serum Levels of Circulating Immunoinflammation-Related Protein Complexes Are Associated with Cancer. Journal of Proteome Research 2014; 13(2): 710 doi: 10.1021/pr4008255
|
| 71 |
Judith Y.M.N. Engwegen, Annekatrien C.T.M. Depla, Marianne E. Smits, Annemieke Cats, Henriëtte Tuynman, Henk A. Van Heukelem, Pleun Snel, Wouter Meuleman, Lodewyk F. Wessels, Jan H.M. Schellens, Jos H. Beijnen. Detection of Colorectal Cancer by Serum and Tissue Protein Profiling: A Prospective Study in a Population at Risk. Biomarker Insights 2008; 3: BMI.S790 doi: 10.4137/BMI.S790
|
| 72 |
Francesca Maffei, Sabrina Angelini, Giorgio Cantelli Forti, Patrizia Hrelia. Blood Biomarkers Linked to Oxidative Stress and Chronic Inflammation for Risk Assessment of Colorectal Neoplasia. Current Colorectal Cancer Reports 2013; 9(1): 85 doi: 10.1007/s11888-012-0156-z
|
| 73 |
Weigui Sun, Zhangqun Ye, Zhenguo Mi, Tianliang Shi, Cunzhi Han, Sutang Guo. A comparative study on proteomics between LNCap and DU145 cells by quantitative detection and SELDI analysis. Journal of Huazhong University of Science and Technology [Medical Sciences] 2008; 28(2): 174 doi: 10.1007/s11596-008-0215-5
|
| 74 |
Paul Dowling, Lorraine O'Driscoll, Paula Meleady, Michael Henry, Shunil Roy, Jo Ballot, Michael Moriarty, John Crown, Martin Clynes. 2‐D difference gel electrophoresis of the lung squamous cell carcinoma versus normal sera demonstrates consistent alterations in the levels of ten specific proteins. ELECTROPHORESIS 2007; 28(23): 4302 doi: 10.1002/elps.200700246
|
| 75 |
L. Lo Russo, M. Papale, D. Perrone, E. Ranieri, C. Rubini, G. Giannatempo, A. Santarelli, G. Colella, L. Lo Muzio. Salivary Proteomic Signatures of Oral Squamous Cell Carcinoma. European Journal of Inflammation 2012; 10(1): 61 doi: 10.1177/1721727X1201000107
|
| 76 |
Kewal K. Jain. Applications of Biotechnology in Oncology. 2014; : 63 doi: 10.1007/978-1-4614-9245-0_4
|
| 77 |
Jianwei Zhang, Yue Cai, Huabin Hu, Ping Lan, Lei Wang, Meijin Huang, Liang Kang, Xiaojian Wu, Hui Wang, Jiayu Ling, Jian Xiao, Jianping Wang, Yanhong Deng. Nomogram basing pre-treatment parameters predicting early response for locally advanced rectal cancer with neoadjuvant chemotherapy alone: a subgroup efficacy analysis of FOWARC study. Oncotarget 2016; 7(4): 5053 doi: 10.18632/oncotarget.6469
|
| 78 |
Jakob Albrethsen, Anne Kaas, Eugen Schönle, Peter Swift, Mirjana Kocova, Steen Gammeltoft, Lars Hansen, Henrik Bindesbøl Mortensen. Evaluation of a type 1 diabetes serum cohort by SELDI‐TOF MS protein profiling. PROTEOMICS – Clinical Applications 2009; 3(3): 383 doi: 10.1002/prca.200800063
|
| 79 |
Kazuyuki Sogawa, Kenta Noda, Hiroshi Umemura, Masanori Seimiya, Takahisa Kuga, Takeshi Tomonaga, Motoi Nishimura, Fumihiko Kanai, Fumio Imazeki, Hirotaka Takizawa, Masato Yoneda, Atsushi Nakajima, Mikihiro Tsutsumi, Osamu Yokosuka, Fumio Nomura. Serum fibrinogen alpha C‐chain 5.9 kDa fragment as a biomarker for early detection of hepatic fibrosis related to hepatitis C virus. PROTEOMICS – Clinical Applications 2013; 7(5-6): 424 doi: 10.1002/prca.201200094
|
| 80 |
Michela Bertuzzi, Cristina Marelli, Renzo Bagnati, Alessandro Colombi, Roberto Fanelli, Calogero Saieva, Marco Ceroti, Benedetta Bendinelli, Saverio Caini, Luisa Airoldi, Domenico Palli. Plasma clusterin as a candidate pre-diagnosis marker of colorectal cancer risk in the Florence cohort of the European Prospective Investigation into Cancer and Nutrition: a pilot study. BMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1058-7
|
| 81 |
Chandrika J. Piyathilake, Denise K. Oelschlager, Sreelatha Meleth, Edward E. Partridge, William E. Grizzle. Plasma Protein Profiles Differ between Women Diagnosed with Cervical Intraepithelial Neoplasia (CIN) 1 and 3. Cancer Informatics 2006; 2: 117693510600200 doi: 10.1177/117693510600200026
|
| 82 |
Eleonora Forte, Jes M. Sanders, Indira Pla, Vijaya Lakshmi Kanchustambham, Michael A.R. Hollas, Che-Fan Huang, Aniel Sanchez, Katrina N. Peterson, Rafael D. Melani, Alexander Huang, Praneet Polineni, Julianna M. Doll, Zachary Dietch, Neil L. Kelleher, Daniela P. Ladner. Top-Down Proteomics Identifies Plasma Proteoform Signatures of Liver Cirrhosis Progression. Molecular & Cellular Proteomics 2024; : 100876 doi: 10.1016/j.mcpro.2024.100876
|
| 83 |
Nikhil Pawa, Tan Arulampalam, John D. Norton. Screening for colorectal cancer: established and emerging modalities. Nature Reviews Gastroenterology & Hepatology 2011; 8(12): 711 doi: 10.1038/nrgastro.2011.205
|
| 84 |
Wouter Meuleman, Judith YMN Engwegen, Marie-Christine W Gast, Jos H Beijnen, Marcel JT Reinders, Lodewyk FA Wessels. Comparison of normalisation methods for surface-enhanced laser desorption and ionisation (SELDI) time-of-flight (TOF) mass spectrometry data. BMC Bioinformatics 2008; 9(1) doi: 10.1186/1471-2105-9-88
|
| 85 |
M Hepponstall, V Ignjatovic, S Binos, C Attard, V Karlaftis, Y d’Udekem, P Monagle, I E Konstantinov. Cardiopulmonary bypass changes the plasma proteome in children undergoing tetralogy of Fallot repair. Perfusion 2015; 30(7): 556 doi: 10.1177/0267659114566065
|
| 86 |
Santiago Marfà, Wladimiro Jimenez. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2015; : 1 doi: 10.1007/978-94-007-7742-2_7-1
|
| 87 |
Anouck Huijbers, Berit Velstra, Tim J. A. Dekker, Wilma E. Mesker, Yuri E. M. van der Burgt, Bart J. Mertens, André M. Deelder, Rob A. E. M. Tollenaar. Proteomic Serum Biomarkers and Their Potential Application in Cancer Screening Programs. International Journal of Molecular Sciences 2010; 11(11): 4175 doi: 10.3390/ijms11114175
|
| 88 |
Hui Chen, Zan Lin, Lin Mo, Chao Tan. Identification of Colorectal Cancer Using Near-Infrared Spectroscopy and Adaboost with Decision Stump. Analytical Letters 2017; 50(16): 2608 doi: 10.1080/00032719.2017.1310880
|
| 89 |
|
| 90 |
Amir M. Sheikh, Cindy Barrett, Nestor Villamizar, Oscar Alzate, Sara Miller, John Shelburne, Andrew Lodge, Jeffrey Lawson, James Jaggers. Proteomics of cerebral injury in a neonatal model of cardiopulmonary bypass with deep hypothermic circulatory arrest. The Journal of Thoracic and Cardiovascular Surgery 2006; 132(4): 820 doi: 10.1016/j.jtcvs.2006.07.002
|
| 91 |
Matilda Holm, Sakari Joenväärä, Mayank Saraswat, Harri Mustonen, Tiialotta Tohmola, Ari Ristimäki, Risto Renkonen, Caj Haglund. Identification of several plasma proteins whose levels in colorectal cancer patients differ depending on outcome. FASEB BioAdvances 2019; 1(12): 723 doi: 10.1096/fba.2019-00062
|
| 92 |
Hao Li, Kamala Vanarsa, Ting Zhang, Sanam Soomro, Pietro Antonio Cicalese, Valeria Duran, Shobha Dasari, Kyung Hyun Lee, Claudia Pedroza, John B. Kisiel, Huanlong Qin, Robert S. Bresalier, Nicholas Chia, Chandra Mohan. Comprehensive aptamer-based screen of 1317 proteins uncovers improved stool protein markers of colorectal cancer. Journal of Gastroenterology 2021; 56(7): 659 doi: 10.1007/s00535-021-01795-y
|
| 93 |
Sofiya Kolusheva, Rami Yossef, Aleksandra Kugel, Nirit Hanin-Avraham, Meital Cohen, Eitan Rubin, Angel Porgador. A Novel “Reactomics” Approach for Cancer Diagnostics. Sensors 2012; 12(5): 5572 doi: 10.3390/s120505572
|
| 94 |
Judith Y. M. N. Engwegen, Marieke Alberts, Jaco C. Knol, Connie R. Jimenez, Annekatrien C. T. M. Depla, Henriëtte Tuynman, Henk A. van Heukelem, Pleun Snel, Marianne E. Smits, Annemieke Cats, Jan H. M. Schellens, Jos H. Beijnen. Influence of variations in sample handling on SELDI‐TOF MS serum protein profiles for colorectal cancer. PROTEOMICS – Clinical Applications 2008; 2(6): 936 doi: 10.1002/prca.200780068
|
| 95 |
N. Deckers, P. Dorny, K. Kanobana, J. Vercruysse, A.E. Gonzalez, B. Ward, M. Ndao. Use of ProteinChip technology for identifying biomarkers of parasitic diseases: The example of porcine cysticercosis (Taenia solium). Experimental Parasitology 2008; 120(4): 320 doi: 10.1016/j.exppara.2008.08.013
|
| 96 |
Michael T. Davis, Paul Auger, Chris Spahr, Scott D. Patterson. Cancer biomarker discovery via low molecular weight serum proteome profiling – Where is the tumor?. PROTEOMICS – Clinical Applications 2007; 1(12): 1545 doi: 10.1002/prca.200700141
|
| 97 |
Konstantinos K. Tsilidis, Casey Branchini, Eliseo Guallar, Kathy J. Helzlsouer, Thomas P. Erlinger, Elizabeth A. Platz. C‐reactive protein and colorectal cancer risk: A systematic review of prospective studies. International Journal of Cancer 2008; 123(5): 1133 doi: 10.1002/ijc.23606
|
| 98 |
Hannah Bateson, Saira Saleem, Paul M. Loadman, Chris W. Sutton. Use of matrix-assisted laser desorption/ionisation mass spectrometry in cancer research. Journal of Pharmacological and Toxicological Methods 2011; 64(3): 197 doi: 10.1016/j.vascn.2011.04.003
|
| 99 |
Hui Chen, Zan Lin, Lin Mo, Tong Wu, Chao Tan. Near-Infrared Spectroscopy as a Diagnostic Tool for Distinguishing between Normal and Malignant Colorectal Tissues. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/472197
|
| 100 |
Valeria R. Mas, Daniel G. Maluf, Kellie J. Archer, Kenneth Yanek, Karen Bornstein, Robert A. Fisher. Proteomic Analysis of HCV Cirrhosis and HCV-Induced HCC: Identifying Biomarkers for Monitoring HCV-Cirrhotic Patients Awaiting Liver Transplantation. Transplantation 2009; 87(1): 143 doi: 10.1097/TP.0b013e318191c68d
|
| 101 |
Dongjian Song, Lifang Yue, Hao Li, Junjie Zhang, Zechen Yan, Yingzhong Fan, Heying Yang, Qiuliang Liu, Da Zhang, Ziqiang Xia, Pan Qin, Jia Jia, Ming Yue, Jiekai Yu, Shu Zheng, Fuquan Yang, Jiaxiang Wang. Diagnostic and prognostic role of serum protein peak at 6449 m/z in gastric adenocarcinoma based on mass spectrometry. British Journal of Cancer 2016; 114(8): 929 doi: 10.1038/bjc.2016.52
|
| 102 |
N. A. Pakharukova, L. Kh. Pastushkova, S. A. Moshkovskii, I. M. Larina. Variability of the healthy human proteome. Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry 2011; 5(3): 203 doi: 10.1134/S1990750811030097
|
| 103 |
Timo Gemoll, Uwe Johannes Roblick, Gert Auer, Hans Jörnvall, Jens Karsten Habermann. SELDI-TOF serum proteomics and colorectal cancer: A current overview. Archives of Physiology and Biochemistry 2010; 116(4-5): 188 doi: 10.3109/13813455.2010.495130
|
| 104 |
Ying Lin, William S. Dynan, Jeffrey R. Lee, Zhao-Hua Zhu, Robert R. Schade. The Current State of Proteomics in GI Oncology. Digestive Diseases and Sciences 2009; 54(3): 431 doi: 10.1007/s10620-008-0656-5
|
| 105 |
Joost P.J.J. Hegmans, Joris D. Veltman, Eric T. Fung, Thorsten Verch, Curtis Glover, Fujun Zhang, W. Jeffrey Allard, Davy T'Jampens, Henk C. Hoogsteden, Bart N. Lambrecht, Joachim Aerts. Protein Profiling of Pleural Effusions to Identify Malignant Pleural Mesothelioma Using SELDI-TOF MS. Technology in Cancer Research & Treatment 2009; 8(5): 323 doi: 10.1177/153303460900800502
|
| 106 |
Claudia Martelli, Federica Iavarone, Federica Vincenzoni, Diana Valeria Rossetti, Luca D'Angelo, Gianpiero Tamburrini, Massimo Caldarelli, Concezio Di Rocco, Irene Messana, Massimo Castagnola, Claudia Desiderio. Proteomic characterization of pediatric craniopharyngioma intracystic fluid by LC‐MS top‐down/bottom‐up integrated approaches. ELECTROPHORESIS 2014; 35(15): 2172 doi: 10.1002/elps.201300578
|
| 107 |
Meital Cohen, Rami Yossef, Tamir Erez, Aleksandra Kugel, Michael Welt, Mark M. Karpasas, Jonathan Bones, Pauline M. Rudd, Julien Taieb, Herve Boissin, Dror Harats, Karin Noy, Yoram Tekoah, Rachel G. Lichtenstein, Eitan Rubin, Angel Porgador, Hana Algül. Serum Apolipoproteins C-I and C-III Are Reduced in Stomach Cancer Patients: Results from MALDI-Based Peptidome and Immuno-Based Clinical Assays. PLoS ONE 2011; 6(1): e14540 doi: 10.1371/journal.pone.0014540
|
| 108 |
Julia C.F. Quintanilha, Alexander B. Sibley, Yingmiao Liu, Donna Niedzwiecki, Susan Halabi, Layne Rogers, Bert O’Neil, Hedy Kindler, William Kelly, Alan Venook, Howard L. McLeod, Mark J. Ratain, Andrew B. Nixon, Federico Innocenti, Kouros Owzar. Common variation in a long non-coding RNA gene modulates variation of circulating TGF-β2 levels in metastatic colorectal cancer patients (Alliance). BMC Genomics 2024; 25(1) doi: 10.1186/s12864-024-10354-7
|
| 109 |
M.A. Karpova, S.A. Moshkovskii, I.Y. Toropygin, A.I. Archakov. Cancer-specific MALDI-TOF profiles of blood serum and plasma: Biological meaning and perspectives. Journal of Proteomics 2010; 73(3): 537 doi: 10.1016/j.jprot.2009.09.011
|
| 110 |
Ming Zhi Zhang, Zhen Chang Sun, Xiao Rui Fu, Fei Fei Nan, Qing Xia Fan, Xing Ai Wu, Li Geng, Wang Ma, Rui Lin Wang. Analysis of serum proteome profiles of non-Hodgkin lymphoma for biomarker identification. Journal of Proteomics 2009; 72(6): 952 doi: 10.1016/j.jprot.2009.03.009
|
| 111 |
Hui Chen, Zan Lin, Chao Tan. Probabilistic Characterization Using Partial Least Squares and Near-Infrared Spectroscopy for Cancer Diagnosis. Analytical Letters 2015; 48(14): 2234 doi: 10.1080/00032719.2015.1027900
|
| 112 |
Kush K. Patel, Khosrow Kashfi. Lipoproteins and cancer: The role of HDL-C, LDL-C, and cholesterol-lowering drugs. Biochemical Pharmacology 2022; 196: 114654 doi: 10.1016/j.bcp.2021.114654
|
| 113 |
Anne K. Callesen, Ole Mogensen, Andreas K. Jensen, Torben A. Kruse, Torben Martinussen, Ole N. Jensen, Jonna S. Madsen. Reproducibility of mass spectrometry based protein profiles for diagnosis of ovarian cancer across clinical studies: A systematic review. Journal of Proteomics 2012; 75(10): 2758 doi: 10.1016/j.jprot.2012.02.007
|